Olink Holding AB (publ) (OLK)

NASDAQ: OLK · IEX Real-Time Price · USD
19.95
-0.01 (-0.05%)
Feb 3, 2023, 4:00 PM EST - Market closed
-0.05%
Market Cap 2.38B
Revenue (ttm) 125.65M
Net Income (ttm) -26.25M
Shares Out 119.10M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 256,391
Open 19.66
Previous Close 19.96
Day's Range 19.50 - 20.04
52-Week Range 8.39 - 26.47
Beta n/a
Analysts Buy
Price Target 23.46 (+17.59%)
Earnings Date Feb 21, 2023

About OLK

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company's products also comprise Olink Sig... [Read more]

Sector Healthcare
IPO Date Mar 25, 2021
Employees 416
Stock Exchange NASDAQ
Ticker Symbol OLK
Full Company Profile

Financial Performance

In 2021, OLK's revenue was $94.97 million, an increase of 75.66% compared to the previous year's $54.07 million. Losses were -$38.34 million, 465.5% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for OLK stock is "Buy." The 12-month stock price forecast is $23.46, which is an increase of 17.59% from the latest price.

Price Target
$23.46
(17.59% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Why Is Olink (OLK) Stock Down 17% Today?

Olink (NASDAQ: OLK) stock is falling on Thursday as investors react to the pricing of a public offering of the proteomics company's shares. The offering prices 5,831,028 American Depository Shares ( ...

2 weeks ago - InvestorPlace

Olink Holding AB (publ) announces pricing of public offering of American Depositary Shares

Uppsala, Sweden, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of a public offering of 5,831,028 American Depositary S...

2 weeks ago - GlobeNewsWire

Olink Holding AB (publ) launches public offering of American Depositary Shares

Uppsala, Sweden, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the launch of a public offering of 5,831,028 American Depositary Sh...

2 weeks ago - GlobeNewsWire

Olink announces preliminary unaudited revenue for the fourth quarter and full year 2022 and provides outlook for 2023

UPPSALA, Sweden, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink” or the “Company”) (Nasdaq: OLK), today announced preliminary unaudited revenue for the fourth quarter and year ended...

3 weeks ago - GlobeNewsWire

Olink to participate in the 41st Annual JP Morgan Healthcare Conference

UPPSALA, Sweden, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced its participation in the 41st Annual JP Morgan Healthcare Conference.

1 month ago - GlobeNewsWire

5 Winning Medical Product Stocks That Still Have Room to Run

Despite ongoing macro challenges, medical product stocks like Cardinal Health (CAH), TransMedics Group (TMDX), Olink Holding (OLK), Silk Road Medical (SILK) and Neuronetics (STIM) are likely to gain f...

Other symbols: CAHSILKSTIMTMDX
1 month ago - Zacks Investment Research

DISCOVERY LIFE SCIENCES LAUNCHES WORLD-CLASS PROTEOMIC SERVICES DIVISION SUPPORTED BY LEADING TECHNOLOGY PARTNERS

Creates a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis to support drug and diagnostic development HUNTSVILLE, Ala. , Dec. 14, 2022 /PRN...

Other symbols: SEER
1 month ago - PRNewsWire

Is Olink Holding (OLK) Outperforming Other Medical Stocks This Year?

Here is how Olink Holding AB publ Sponsored ADR (OLK) and Oncolytics Biotech Inc. (ONCY) have performed compared to their sector so far this year.

2 months ago - Zacks Investment Research

5 Best Stocks to Invest in for Solid Earnings Acceleration

Invest in stocks like MacroGenics (MGNX), NerdWallet (NRDS) & LivePerson (LPSN) at the moment for superb earnings acceleration.

Other symbols: LPSNMGNXNRDSRAMP
2 months ago - Zacks Investment Research

Maria Martin-Grau, at the University of Valencia, Spain is selected for the 2022 Novelties in Biomarkers award

UPPSALA, Sweden, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) is proud to announce the 2022 winner of the young researchers' award, Novelties in Biomarkers, Maria Martin-Gra...

2 months ago - GlobeNewsWire

Announcing Olink® Flex, a new, unique and fully flexible low-plex proteomics solution using absolute quantification

UPPSALA, Sweden, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now taking orders for Olink ® Flex, a fully flexible made-to-order product to select...

2 months ago - GlobeNewsWire

Olink Holding AB publ Sponsored ADR (OLK) Reports Q3 Loss, Tops Revenue Estimates

Olink Holding AB publ Sponsored ADR (OLK) delivered earnings and revenue surprises of 91.67% and 9.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead...

3 months ago - Zacks Investment Research

Olink reports third quarter 2022 financial results

UPPSALA, Sweden, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the third quarter of 2022.

3 months ago - GlobeNewsWire

Olink announces milestone achievement of 1,000 peer-reviewed articles citing use of PEA technology

UPPSALA, Sweden, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the achievement of more than one thousand peer-reviewed publications citing the use o...

3 months ago - GlobeNewsWire

Olink Holding AB publ Sponsored ADR (OLK) Moves to Buy: Rationale Behind the Upgrade

Olink Holding AB publ Sponsored ADR (OLK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near ...

3 months ago - Zacks Investment Research

7 Short-Squeeze Stocks to Buy for Contrarian Investors

Short-squeeze stocks offer tremendous upside potential for people who laugh in the face of danger. Fundamentally, the concept involves betting against the pessimistic crowd with the aim of sparking a ...

4 months ago - InvestorPlace

Discovery Life Sciences partners with Olink to support proteomics research and accelerate precision medicine programs

UPPSALA, Sweden, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that it has entered into an agreement with Discovery Life Sciences™ (Discovery) to e...

4 months ago - GlobeNewsWire

DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE

HUNTSVILLE, Ala. , Sept. 20, 2022 /PRNewswire/ -- Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, has entered into an agreement with Olink Holding AB (publ) (Olink) a...

4 months ago - PRNewsWire

Multi-omics service provider Sequanta completes extended concordance validation of Olink® Target 48/96 and Olink® Explore

UPPSALA, Sweden, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that Sequanta Technologies, a leading multi-omics service provider based in China, successfull...

5 months ago - GlobeNewsWire

Olink strengthens management team for continued leadership in the modern proteomics era

UPPSALA, Sweden, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced several appointments in its leadership structure.

5 months ago - GlobeNewsWire

Olink to participate in September investor conferences

UPPSALA, Sweden, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor conferences:

5 months ago - GlobeNewsWire

Olink Holding AB publ Sponsored ADR (OLK) Reports Q2 Loss, Tops Revenue Estimates

Olink Holding AB publ Sponsored ADR (OLK) delivered earnings and revenue surprises of 69.23% and 3.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for ...

6 months ago - Zacks Investment Research

Olink to report second quarter 2022 financial results on August 11, 2022

UPPSALA, Sweden, July 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2022 before the market op...

7 months ago - GlobeNewsWire

Release of Olink® Analyze 3.1 streamlines proteomic analysis to connect data to biological insight

UPPSALA, Sweden, June 28, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the release of Olink® Analyze 3.1. Olink® Analyze is an R software package, a collection of fun...

7 months ago - GlobeNewsWire

UK Biobank Pharma Proteomics Project publishes early results from its pioneering proteomics research

UPPSALA, Sweden, June 21, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) announced that a publication describing the early findings of proteomics research conducted by the UK Biobank P...

8 months ago - GlobeNewsWire